Purchase Order HT941024P0092
Award Date
7/1/24
Potential Completion Date
6/30/29
Potential Value
$2.1M
Federal Agency
Defense Health Agency
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6630 - Chemical Analysis Instruments
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $343,702.11 firm fixed price delivery order contract to provide Histology Stains. The contract has a period of performance starting on January 20, 2023 through January 26, 2023, with all work to be conducted by Roche Diagnostics Corporation at their facility located in San Diego, California.</p>
This is a firm-fixed-price purchase order awarded by the Defense Health Agency to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $1,008,529.39, is for a cost-per-stain lease of an immunohistochemistry (IHC) staining platform to support the Department of Pathology at Madigan Army Medical Center in Tacoma, Washington. This is a new 5-year contract, with a base period...
This is a federal contract awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide a lease of a slide staining platform. The contract has a ceiling value of $362,038.75 and a period of performance from October 1, 2021 through September 30, 2026. The contract is a firm fixed price purchase order, with no set-aside designation. The contract was awarded under a pre-solicitation that was posted in May 2021, seeking two...
This federal contract award was issued by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $178,187.52 Firm Fixed Price delivery order contract provides immunohistochemistry (IHC) assays, slide stainers, cytology/histology reagents, and other consumables in support of the Naval Medical Center in Portsmouth, Virginia. The contract...
This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $712,750.00, was awarded by the Defense Health Agency (DHA) for "IHC COST PER TEST" services. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract vehicle, likely a Blanket Purchase Agreement (BPA) or Indefinite...
This is a firm-fixed price purchase order awarded by the Defense Health Agency to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer. The $152,856.00 contract is for providing automated immunohistochemistry (IHC) slide staining platforms, antibody stains, reagents, and supplies to support the Anatomic Pathology mission at Madigan Army Medical Center in Tacoma, Washington. The contract has a period of performance through June 30, 2025....
This is a delivery order contract awarded by the Defense Health Agency to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $178,187.52, is for the provision of immunohistochemistry (IHC) cost per test, slide stainer, cytology/histology reagents, and consumables in support of the Naval Medical Center in Portsmouth, Virginia. The contract does not...
The Defense Health Agency awarded a firm fixed-price delivery order to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, for the provision of immunohistochemical slides at a potential value of $712,750.00. The contract does not have a set-aside designation. Roche Diagnostics has a history of providing critical medical equipment, reagents, and laboratory services to federal agencies including the Departments of Veterans Affairs, Defense, and Health and Human Services...
This is a firm fixed-price delivery order awarded by the Department of the Navy Bureau of Medicine and Surgery to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for the provision of slide stainers used in cytology and histology applications. The contract has a potential value of $553,758.14 and a completion date of October 1, 2017. Roche Diagnostics has held multiple General Services Administration (GSA) Schedule contracts and Indefinite Delivery Contracts (IDCs) with...
The U.S. Department of the Navy Bureau of Medicine and Surgery awarded a $131,758.96 firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The award is for numerous antibodies in various quantities for the Ventana Benchmark System used in NMCSD laboratories. This award does not have a set-aside designation and was made on a sole-source basis due to only one source being able to meet...